[HTML][HTML] In silico drug combination discovery for personalized cancer therapy
Background Drug combination therapy, which is considered as an alternative to single drug
therapy, can potentially reduce resistance and toxicity, and have synergistic efficacy. As drug …
therapy, can potentially reduce resistance and toxicity, and have synergistic efficacy. As drug …
[HTML][HTML] In silico drug combination discovery for personalized cancer therapy
M Jeon, S Kim, S Park, H Lee, J Kang - BMC Systems Biology, 2018 - ncbi.nlm.nih.gov
Background Drug combination therapy, which is considered as an alternative to single drug
therapy, can potentially reduce resistance and toxicity, and have synergistic efficacy. As drug …
therapy, can potentially reduce resistance and toxicity, and have synergistic efficacy. As drug …
In silico drug combination discovery for personalized cancer therapy.
M Jeon, S Kim, S Park, H Lee… - BMC Systems Biology, 2018 - search.ebscohost.com
Background: Drug combination therapy, which is considered as an alternative to single drug
therapy, can potentially reduce resistance and toxicity, and have synergistic efficacy. As drug …
therapy, can potentially reduce resistance and toxicity, and have synergistic efficacy. As drug …
In silico drug combination discovery for personalized cancer therapy
M Jeon, S Kim, S Park, H Lee, J Kang - BMC Systems Biology, 2018 - go.gale.com
Background Drug combination therapy, which is considered as an alternative to single drug
therapy, can potentially reduce resistance and toxicity, and have synergistic efficacy. As drug …
therapy, can potentially reduce resistance and toxicity, and have synergistic efficacy. As drug …
In silico drug combination discovery for personalized cancer therapy
M Jeon, S Kim, S Park, H Lee… - BMC systems …, 2018 - pubmed.ncbi.nlm.nih.gov
Background Drug combination therapy, which is considered as an alternative to single drug
therapy, can potentially reduce resistance and toxicity, and have synergistic efficacy. As drug …
therapy, can potentially reduce resistance and toxicity, and have synergistic efficacy. As drug …
In silico drug combination discovery for personalized cancer therapy.
M Jeon, S Kim, S Park, H Lee, J Kang - BMC Systems Biology, 2018 - europepmc.org
BACKGROUND: Drug combination therapy, which is considered as an alternative to single
drug therapy, can potentially reduce resistance and toxicity, and have synergistic efficacy. As …
drug therapy, can potentially reduce resistance and toxicity, and have synergistic efficacy. As …
[HTML][HTML] In silico drug combination discovery for personalized cancer therapy
M Jeon, S Kim, S Park, H Lee… - BMC Systems …, 2018 - bmcsystbiol.biomedcentral.com
Drug combination therapy, which is considered as an alternative to single drug therapy, can
potentially reduce resistance and toxicity, and have synergistic efficacy. As drug combination …
potentially reduce resistance and toxicity, and have synergistic efficacy. As drug combination …
In silico drug combination discovery for personalized cancer therapy
M Jeon, S Kim, S Park, H Lee, J Kang - BMC Systems Biology, 2018 - pure.korea.ac.kr
Background: Drug combination therapy, which is considered as an alternative to single drug
therapy, can potentially reduce resistance and toxicity, and have synergistic efficacy. As drug …
therapy, can potentially reduce resistance and toxicity, and have synergistic efficacy. As drug …
[PDF][PDF] In silico drug combination discovery for personalized cancer therapy
M Jeon, S Kim, S Park, H Lee, J Kang - 2018 - academia.edu
Background: Drug combination therapy, which is considered as an alternative to single drug
therapy, can potentially reduce resistance and toxicity, and have synergistic efficacy. As drug …
therapy, can potentially reduce resistance and toxicity, and have synergistic efficacy. As drug …
[PDF][PDF] In silico drug combination discovery for personalized cancer therapy
M Jeon, S Kim, S Park, H Lee, J Kang - 2018 - bmcsystbiol.biomedcentral.com
Background: Drug combination therapy, which is considered as an alternative to single drug
therapy, can potentially reduce resistance and toxicity, and have synergistic efficacy. As drug …
therapy, can potentially reduce resistance and toxicity, and have synergistic efficacy. As drug …